Investor Relations :: ProPhase Labs, Inc. (PRPH)

Latest News

Apr 22, 2021

ProPhase Labs to Provide COVID-19 Testing for Oyster Bay Township in New York

Apr 15, 2021

ProPhase Labs to Host First Quarter 2021 Financial Results Conference Call on Thursday, May 13, 2021 at 4:30 p.m. Eastern Time

Mar 31, 2021

ProPhase Labs Reports Fourth Quarter and Full Year 2020 Financial Results

View All News

Investor Presentation

View Presentation

First Quarter 2021 Financial Results Conference Call

View Event Add to Calendar View All

FY 2020

Fiscal Year Ended Dec 31, 2020

Earnings Release

Earnings Webcast

10-K

PDF HTML

XBRL

ZIP XLS HTML

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2020

Company Overview

ProPhase Labs (NASDAQ: PRPH) is a diversified medical science and technology company. The Company’s laboratory testing subsidiary, ProPhase Diagnostics, offers SARS-CoV-2 (COVID-19) and COVID-19 viral mutation PCR tests through both saliva and nasal swab methods at its CLIA certified laboratories. Critical to COVID testing, results are typically provided in under 24 hours. ProPhase Labs also has deep experience with OTC consumer healthcare products and dietary supplements.

View Management Team View Board of Directors

Investor Contact Information

Company

ProPhase Labs, Inc.
711 Stewart Ave
Suite 200
Garden City, NY 11530

Investor Relations

MZ Group - MZ North America
Chris Tyson
Managing Director
T: 949-491-8235
PRPH@mzgroup.us
www.mzgroup.us

© Copyright 2021 - ProPhase Labs, Inc.

Market Data copyright © 2021 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.